Regulation of temporal cytokine production by co-stimulation receptors in TCR-T cells is lost in CAR-T cells
Ashna PateliD, Mikhail A. KutuzoviD, Michael Loran DustiniD, P. Anton van der MerweiD, Omer DushekiD
Abstract
CD8+ T cells contribute to immune responses by producing cytokines when their T cell receptors (TCRs) recognise peptide antigens on major-histocompability-complex (pMHC) class I. However, excessive cytokine production can be harmful. For example, cytokine release syndrome (CRS) is a common toxicity observed in treatments that activate T cells, including chimeric antigen receptor (CAR)-T cell therapy. While engagement of costimulatory receptors is well known to enhance cytokine production, we have limited knowledge of their ability to regulate the kinetics of cytokine production by CAR-T cells. Here we compare early (0-12 hours) and late (12-20 hours) production of IFN-{gamma}, IL-2, and TNF- production by T cells stimulated via TCR or CARs in the presence or absence ligands for CD2, LFA-1, CD28, CD27, and 4-1BB. For T cells expressing TCRs and 1st-generation CARs, activation by antigen alone was sufficient to stimulate early cytokine production, while co-stimulation by CD2 and 4-1BB was required to maintain late cytokine production. In contrast, T cells expressing 2nd-generation CARs, which have intrinsic costimulatory signalling motifs, produce high levels of cytokines in both early and late periods in the absence of costimulatory receptor ligands. Losing the requirement for costimulation for sustained cytokine production may contribute to the effectiveness and/or toxicity of 2nd-generation CAR-T cell therapy. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=89 SRC="FIGDIR/small/581341v1_ufig1.gif" ALT="Figure 1"> View larger version (15K): org.highwire.dtl.DTLVardef@1d59d68org.highwire.dtl.DTLVardef@1512832org.highwire.dtl.DTLVardef@126134corg.highwire.dtl.DTLVardef@bd104d_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 7
- FWCI
- 1.20
- Field percentile
- top 20%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Early induction of severe cytokine release syndrome by rapidly generated CAR T cells in a preclinical mouse model
N. Ho, A. Jamali, … C. J. Buchholz·bioRxiv·Nov 12, 2022
- Differential impact of TNFRSF co-stimulation on CD8+ T cell cytokine production by feedback control of surface receptor expression
J. Nguyen, J. Pettmann, … O. Dushek·bioRxiv·Jul 2, 2021
- The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicities
Payal Goala, Yongliang Zhang, … Marco L. Davila·bioRxiv·Mar 6, 2025
- B-cell activating factor plays a critical role in CAR-T cell-associated cytokine release syndrome
Claire E. Fritz, Leland L. Metheny, … Reshmi Parameswaran·bioRxiv·Nov 22, 2025
- High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells
Russell W Cochrane, Rob A. Robino, … Leonardo M. R. Ferreira·Molecular Therapy — Methods & Clinical DevelopmentPeer-reviewed·Nov 18, 2024
- Marker genes for predicting cytokine release syndrome in vitro before CAR T cell infusion
Mengxiang Chen, Tao Wu, … Yunhong Huang·bioRxiv·May 26, 2025